Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

NCT04438824 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Well-differentiated/Dedifferentiated Liposarcoma

Interventions

DRUG: INCMGA00012
DRUG: Palbociclib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]